Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.43 |
| ▸ | CPT2 | P23786 | 1/20 | 0.35 |
| ▸ | ACLY | P53396 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5862554 | 0.85 | ACLY (0.38) | CPT2ACLY | |
| SCHEMBL1553184 | 0.84 | TSHR (0.39) | CPT2ACLY | |
| Ammonia Solution, Strong SCHEMBL9273494 | 0.83 | CPT2 (0.36) | TDP1CPT2ACLY | |
| Ammonia Solution, Strong SCHEMBL6522827 | 0.83 | CPT2 (0.36) | TDP1CPT2ACLY | |
| SCHEMBL9236937 | 0.83 | CPT2 (0.36) | CPT2ACLY | |
| Ammonia Solution, Strong SCHEMBL10939985 | 0.83 | CPT2 (0.36) | TDP1CPT2ACLY | |
| SCHEMBL27534725 | 0.82 | CPT2 (0.35) | CPT2ACLY | |
| SCHEMBL3071719 | 0.81 | TDP1 (0.38) | TDP1CPT2ACLY | |
| SCHEMBL290602 | 0.80 | SMN1; SMN2 (0.41) | TDP1CPT2ACLYSMN1; SMN2SLC22A6 | |
| Hydrochloric Acid SCHEMBL11284194 | 0.79 | SMN1; SMN2 (0.40) | TDP1CPT2ACLYSMN1; SMN2SLC22A6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116829131-B | Olanzapine transdermal drug delivery system and preparation method and application thereof | 新领医药技术(深圳)有限公司 | 2024-05-07 | — | — | CN | disclosed |
| CN-117815210-A | Risperidone transdermal application system and preparation method and application thereof | 新领医药技术(深圳)有限公司 | 2024-04-05 | — | — | CN | disclosed |
| CN-117157062-A | Transdermal patch for inhibiting drug crystallization and preparation method thereof | 新领医药技术(深圳)有限公司 | 2023-12-01 | — | — | CN | disclosed |
| CN-116829131-A | Olanzapine transdermal drug delivery system and preparation method and application thereof | 新领医药技术(深圳)有限公司 | 2023-09-29 | — | — | CN | disclosed |
| EP-3130676-A1 | MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION | Rice University (US) | 2017-02-15 | — | — | EP | disclosed |
| EP-1781797-B1 | MUTANT E. COLI STRAIN WITH INCREASED SUCCINIC ACID PRODUCTION | RICE UNIVERSITY (US) | 2016-10-19 | — | — | EP | disclosed |
| US-20160117440-A1 | SYSTEM AND METHOD FOR AUTOMATED PREDICTION OF VULNERABILITIES IN BIOLOGICAL SAMPLES | MEMORIAL SLOAN-KETTERING CANCER CENTER | 2016-04-28 | — | — | US | disclosed |
| EP-3004390-A1 | SYSTEM AND METHOD FOR AUTOMATED PREDICTION OF VULNERABILITIES IN BIOLOGICAL SAMPLES | Memorial Sloan Kettering Cancer Center (US) | 2016-04-13 | — | — | EP | disclosed |
| WO-2014194092-A1 | SYSTEM AND METHOD FOR AUTOMATED PREDICTION OF VULNERABILITIES IN BIOLOGICAL SAMPLES | MEMORIAL SLOAN-KETTERING CANCER CENTER (US) | 2014-12-04 | — | — | WO | disclosed |
| US-7790416-B2 | Mutant E. coli strain with increased succinic acid production | RICE UNIVERSITY (US) | 2010-09-07 | — | — | US | disclosed |
| US-20070184539-A1 | Mutant E. coli Strain with Increased Succinic Acid Production | RICE UNIVERSITY (US) | 2007-08-09 | — | — | US | disclosed |
| EP-1789569-A2 | HIGH SUCCINATE PRODUCING BACTERIA | Rice University (US) | 2007-05-30 | — | — | EP | disclosed |
| US-7223567-B2 | Mutant E. coli strain with increased succinic acid production | RICE UNIVERSITY (US) | 2007-05-29 | — | — | US | disclosed |
| US-20060073577-A1 | High succinate producing bacteria | NATIONAL SCIENCE FOUNDATION | 2006-04-06 | — | — | US | disclosed |
| WO-2006034156-A2 | HIGH SUCCINATE PRODUCING BACTERIA | RICE UNIVERSITY (US) | 2006-03-30 | — | — | WO | disclosed |
| US-20060046288-A1 | Mutant E. coli strain with increased succinic acid production | NATIONAL SCIENCE FOUNDATION | 2006-03-02 | — | — | US | disclosed |
| US-6303351-B1 | GENERATING PREFERENTIAL COMPOUND; FEED BIOREATOR OXYGEN, CARBON SOURCE AND NITROGEN SOURCE, FERMENT, CONTINUOUSLY WITHDRAW FERMENTATION PRODUCT AND RECOVER PREFERENTIAL COMPOUND | Anastassiadis, Savas | 2001-10-16 | — | — | US | disclosed |
| US-4075093-A | PERMSELECTIVE MEMBRANE | JOH. A. BENCKISER GMBH (DT) | 1978-02-21 | — | — | US | disclosed |
| US-3997399-A | CANDIDA LIPOLYTIC YEAST | INSTITUT FRANCAIS DU PETROLE, DES CARBURANTS ET LUBRIFIANTS ET ENTREPRISE DE RECHERCHES ET D'ACTIVITIES PETROLIERES ELF (FR) | 1976-12-14 | — | — | US | disclosed |
| US-3773620-A | PROCESS FOR PRODUCING CITRIC ACID ISOCITRIC ACID AND MICROBIAL CELLS BY FERMENTATION | KYOWA HAKKO KOGYO KK | 1973-11-20 | — | — | US | disclosed |